Yizuo Chen

694 total citations
22 papers, 500 citations indexed

About

Yizuo Chen is a scholar working on Molecular Biology, Cancer Research and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Yizuo Chen has authored 22 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Cancer Research and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Yizuo Chen's work include Cancer-related molecular mechanisms research (7 papers), Thyroid Cancer Diagnosis and Treatment (5 papers) and Breast Cancer Treatment Studies (4 papers). Yizuo Chen is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), Thyroid Cancer Diagnosis and Treatment (5 papers) and Breast Cancer Treatment Studies (4 papers). Yizuo Chen collaborates with scholars based in China, Taiwan and France. Yizuo Chen's co-authors include Yinlong Yang, Xiaohua Zhang, Ouchen Wang, Erjie Xia, Lin Lv, Jinmiao Qu, Chen‐Chia Huang, Fan Yang, Jiao Wang and Ruimin Ma and has published in prestigious journals such as Cancer Letters, Annals of Surgical Oncology and Oncotarget.

In The Last Decade

Yizuo Chen

22 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yizuo Chen China 13 272 252 94 94 74 22 500
Manuela Lacerda Portugal 11 170 0.6× 141 0.6× 58 0.6× 39 0.4× 149 2.0× 14 398
Richard D. Sowery Canada 10 285 1.0× 112 0.4× 66 0.7× 44 0.5× 143 1.9× 15 501
Colin Mooney United States 6 139 0.5× 63 0.3× 60 0.6× 244 2.6× 188 2.5× 9 461
Ronghao Wang China 14 428 1.6× 289 1.1× 48 0.5× 25 0.3× 115 1.6× 27 675
Wenkai Zhu China 14 287 1.1× 223 0.9× 45 0.5× 17 0.2× 77 1.0× 21 465
Sushant Tripathy United States 5 196 0.7× 139 0.6× 85 0.9× 22 0.2× 34 0.5× 8 407
Abram Vaccaro United States 8 314 1.2× 50 0.2× 40 0.4× 58 0.6× 172 2.3× 14 523
Frank He United States 7 278 1.0× 75 0.3× 30 0.3× 28 0.3× 175 2.4× 7 483

Countries citing papers authored by Yizuo Chen

Since Specialization
Citations

This map shows the geographic impact of Yizuo Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yizuo Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yizuo Chen more than expected).

Fields of papers citing papers by Yizuo Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yizuo Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yizuo Chen. The network helps show where Yizuo Chen may publish in the future.

Co-authorship network of co-authors of Yizuo Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yizuo Chen. A scholar is included among the top collaborators of Yizuo Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yizuo Chen. Yizuo Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xue, Jingyan, Sheng Huang, Jiaying Chen, et al.. (2021). Overexpression of Long Non-Coding RNA Linc01315 Predicts Poor Prognosis in Breast Cancer. Frontiers in Oncology. 11. 562378–562378. 4 indexed citations
3.
Xia, Erjie, Chen Zheng, Lechi Ye, et al.. (2021). Stress-induced phosphoprotein 1 facilitates breast cancer cell progression and indicates poor prognosis for breast cancer patients. Human Cell. 34(3). 901–917. 6 indexed citations
4.
Chen, Yizuo, et al.. (2020). KCNN4 is a diagnostic and prognostic biomarker that promotes papillary thyroid cancer progression. Aging. 12(16). 16437–16456. 25 indexed citations
5.
Bhandari, Adheesh, et al.. (2020). Immortalization up‐regulated protein promotes tumorigenesis and inhibits apoptosis of papillary thyroid cancer. Journal of Cellular and Molecular Medicine. 24(23). 14059–14072. 4 indexed citations
6.
Wang, Qifeng, Midie Xu, Yifeng Sun, et al.. (2019). Gene Expression Profiling for Diagnosis of Triple-Negative Breast Cancer: A Multicenter, Retrospective Cohort Study. Frontiers in Oncology. 9. 354–354. 31 indexed citations
7.
Xiang, Youqun, et al.. (2019). Upregulation of the long non-coding RNA SPRY4-IT1 predicts poor prognosis in breast cancer.. PubMed. 12(3). 1003–1008. 5 indexed citations
8.
Bhandari, Adheesh, Erjie Xia, Yinghao Wang, Ouchen Wang, & Yizuo Chen. (2018). Laparoscopy‐assisted sentinel lymph node dissection in breast cancer patients. The Breast Journal. 25(1). 172–174. 3 indexed citations
9.
Zhu, Xiaofang, et al.. (2017). Silencing of semaphorin 3C suppresses cell proliferation and migration in MCF‑7 breast cancer cells. Oncology Letters. 14(5). 5913–5917. 16 indexed citations
10.
Wang, Ouchen, Fan Yang, Yehuan Liu, et al.. (2017). C-MYC-induced upregulation of lncRNA SNHG12 regulates cell proliferation, apoptosis and migration in triple-negative breast cancer.. PubMed. 9(2). 533–545. 120 indexed citations
11.
Yang, Yinlong, Jin-Xian Qian, Youqun Xiang, Yizuo Chen, & Jinmiao Qu. (2016). The prognostic value of long noncoding RNA HOTTIP on clinical outcomes in breast cancer. Oncotarget. 8(4). 6833–6844. 36 indexed citations
12.
Ding, Jinhua, et al.. (2016). HOTAIR overexpression correlated with worse survival in patients with solid tumors.. PubMed. 107(6). 392–400. 19 indexed citations
13.
Chen, Yizuo, et al.. (2015). Mitochondrial D-loop Variations in Infertile Women Undergoing in Vitro Fertilization-Embryo Transfer.. PubMed. 60(9-10). 383–8. 1 indexed citations
14.
Yang, Yinlong, et al.. (2014). The use of OK-432 to prevent seroma in extended latissimus dorsi flap donor site after breast reconstruction. Journal of Surgical Research. 193(1). 492–496. 11 indexed citations
15.
Yang, Yinlong, et al.. (2014). Prognostic role of circulating microRNA-21 in cancers: evidence from a meta-analysis. Tumor Biology. 35(7). 6365–6371. 12 indexed citations
16.
Yang, Yinlong, Zimiao Chen, Yizuo Chen, et al.. (2014). Prediction of central compartment lymph node metastasis in papillary thyroid microcarcinoma. Clinical Endocrinology. 81(2). 282–288. 82 indexed citations
17.
Huang, Chen‐Chia & Yizuo Chen. (2013). Electrochemical performance of supercapacitors with KOH activated mesophase carbon microbead electrodes. Journal of the Taiwan Institute of Chemical Engineers. 44(4). 611–616. 22 indexed citations
18.
Yang, Yinlong, Langping Jin, Yizuo Chen, et al.. (2013). Effect and mechanism of the metastasis suppressor gene BRMS1 on the migration of breast cancer cells.. PubMed. 6(10). 908–16. 6 indexed citations
19.
Yang, Yinlong, Xinying Liu, Yizuo Chen, et al.. (2012). Effectiveness of OK-432 (Sapylin) to Reduce Seroma Formation After Axillary Lymphadenectomy for Breast Cancer. Annals of Surgical Oncology. 20(5). 1500–1504. 15 indexed citations
20.
Chen, Yizuo, Canming Chen, Benlong Yang, et al.. (2011). Estrogen receptor-related genes as an important panel of predictors for breast cancer response to neoadjuvant chemotherapy. Cancer Letters. 302(1). 63–68. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026